Project Details
Description
Abstract
The prevalence of adolescent severe obesity is at an all-time high in the U.S. (~8%), and the refractory nature
of this disease has led to uncertainty regarding how to provide effective, safe, scalable, and durable treatments
without placing undue strain on the healthcare system. In 2017, the U.S. Preventive Services Task Force
(USPSTF) released updated screening recommendations concluding that comprehensive, intensive behavioral
interventions with a total of ≥26 contact hours over a period of 2-12 months resulted in weight loss in youth with
obesity, with ≥52 contact hours leading to even greater weight loss and improvements in some cardiometabolic
risk factors. However, the practicality of delivering these types of intensive behavioral services to the millions
of youth with severe obesity in the U.S. is debatable not only because of the treatment-resistant nature of
severe obesity, but also the time-commitment, acceptability, and sustainability of this approach for patients and
their families and the extensive resources required to offer these interventions. While behavior change is an
indispensable component of any effective weight loss approach, adjunctive strategies such as
pharmacotherapy may enhance health outcomes. Pharmacotherapy combined with relatively low-intensity
behavioral counseling (
Status | Active |
---|---|
Effective start/end date | 7/1/20 → 4/30/24 |
Funding
- National Institute of Diabetes and Digestive and Kidney Diseases: $655,324.00
- National Institute of Diabetes and Digestive and Kidney Diseases: $660,663.00
- National Institute of Diabetes and Digestive and Kidney Diseases: $655,324.00
- National Institute of Diabetes and Digestive and Kidney Diseases: $659,445.00
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.